Pharmacokinetic Study of Doxorubicin in Children With Cancer
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
Analyze pharmacokinetics of doxorubicin in children with cancer. Furthermore investigate the
predictive role of troponin and natriuretic peptides for anthracycline-induced cardiotoxicity
.